Thomas Cox
Garvan Institute of Medical Research, NSW, Australia
- This delegate is presenting an abstract at this event.
Thomas currently leads the Matrix and Metastasis Lab at the Garvan Institute of Medical Researching Sydney. The lab focuses on how the extracellular matrix regulates resident cell behaviour and specifically how it contributes to cancer progression, metastasis and response to therapy. Recent work has focussed on developing new techniques to image and catalogue the fibrotic matrix of tumours as well as the systemic role of matrix remodelling in metastatic dissemination. The aim of Thomas’ group is to establish targeting of the cancer matrix as a viable therapeutic approach in the treatment of solid cancers
Presentations this author is a contributor to:
Identifying and targeting FOLFIRINOX resistance mechanisms to improve outcomes in pancreatic cancer (#153)
5:40 PM
Katie Gordon
Welcome Reception & Poster Session 1
Temporally resolved proteomics identifies nidogen-2 as a co-target in pancreatic cancer that modulates fibrosis and therapy response (#235)
5:35 PM
Brooke Pereira
Poster Session 2
Pancreatic cancer secretome reveals PCSK9 as a co-target to sensitise tumours to chemotherapy and reduce metastasis (#244)
5:35 PM
Shona Ritchie
Poster Session 2
Identifying and targeting treatment response mechanisms to improve Gemcitabine/Abraxane performance in Patient-Derived Models of Pancreatic Cancer (#263)
5:35 PM
Alice Tran
Poster Session 2
CANCER 2026